Detalles de la búsqueda
1.
Endogenous secretory leukocyte protease inhibitor inhibits microbial-induced monocyte activation.
Eur J Immunol
; 53(2): e2249964, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36480463
2.
High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence.
Sci Rep
; 12(1): 12174, 2022 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35842496
3.
Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer.
Cytokine Growth Factor Rev
; 59: 22-35, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33602652
4.
Duplication of the IL2RA locus causes excessive IL-2 signaling and may predispose to very early onset colitis.
Mucosal Immunol
; 14(5): 1172-1182, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34226674
5.
Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis.
Oncoimmunology
; 9(1): 1832761, 2020 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33101778
Resultados
1 -
5
de 5
1
Próxima >
>>